富含甘油三酯的脂蛋白残粒水平与代谢：是时候接纳这些被忽视的风险因素了吗？ - Suppr

Triglyceride-rich lipoprotein remnant levels and metabolism: time to adopt these orphan risk factors?

作者信息

Brinton Eliot A, Nanjee M Nazeem, Hopkins Paul N

出版信息

J Am Coll Cardiol. 2004 Jun 16;43(12):2233-5. doi: 10.1016/j.jacc.2004.04.001.

DOI:10.1016/j.jacc.2004.04.001

PMID:15193685

Abstract

摘要

相似文献

Triglyceride-rich lipoprotein remnant levels and metabolism: time to adopt these orphan risk factors?

J Am Coll Cardiol. 2004 Jun 16;43(12):2233-5. doi: 10.1016/j.jacc.2004.04.001.

Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment: a long-term follow-up study.

J Am Coll Cardiol. 2004 Jun 16;43(12):2225-32. doi: 10.1016/j.jacc.2003.11.065.

Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus.

J Am Coll Cardiol. 2004 Jun 16;43(12):2219-24. doi: 10.1016/j.jacc.2003.09.074.

Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).

Am J Cardiol. 2009 Jan 1;103(1):41-5. doi: 10.1016/j.amjcard.2008.08.033. Epub 2008 Oct 10.

Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial).

Am J Cardiol. 2006 Jul 1;98(1):63-5. doi: 10.1016/j.amjcard.2006.01.061. Epub 2006 May 4.

Mechanisms of disease: HDL metabolism as a target for novel therapies.

Nat Clin Pract Cardiovasc Med. 2007 Feb;4(2):102-9. doi: 10.1038/ncpcardio0768.

High-density lipoprotein metabolism: potential therapeutic targets.

Am J Cardiol. 2007 Dec 3;100(11 A):n32-40. doi: 10.1016/j.amjcard.2007.08.011.

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Heart. 2008 Jun;94(6):706-14. doi: 10.1136/hrt.2007.125401.

Rationale for aggressive lipid lowering: evidence from clinical trials.

Expert Rev Cardiovasc Ther. 2004 May;2(3):305-9. doi: 10.1586/14779072.2.3.305.

Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.

Indian Heart J. 2008 May-Jun;60(3):215-22.

引用本文的文献

Effects of prandial challenge on triglyceridemia, glycemia, and pro-inflammatory activity in persons with chronic paraplegia.

J Spinal Cord Med. 2015 Jul;38(4):468-75. doi: 10.1179/2045772314Y.0000000199. Epub 2014 Mar 12.

Triglycerides as vascular risk factors: new epidemiologic insights.

Curr Opin Cardiol. 2009 Jul;24(4):345-50. doi: 10.1097/HCO.0b013e32832c1284.

Remnant lipoproteins and atherosclerosis.

Curr Atheroscler Rep. 2005 Mar;7(2):140-7. doi: 10.1007/s11883-005-0037-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Triglyceride-rich lipoprotein remnant levels and metabolism: time to adopt these orphan risk factors?

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献